Serina Therapeutics (NYSE American: SER) Receives Acceptance of Compliance Plan for Continued Listing
Market Overview Serina Therapeutics, Inc. (NYSE American: SER), a clinical-stage biotechnology company focused on advancing its proprietary POZ Platform™ drug optimization technology, remains under close watch by investors as it navigates regulatory requirements for its stock listing. The company is listed on the NYSE American exchange, where maintaining compliance with continued listing standards is critical for investor confidence and market presence. Recently, Serina Therapeutics (NYSE American: SER) has been addressing…
